Pawel Kalinski Department of Medical Oncology Roswell Park Comprehensive Cancer Center Biography Publications Institution JoVE Articles Pawel Kalinski has not added a biography. If you are Pawel Kalinski and would like to personalize this page please email our Author Liaison for assistance. Publications Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer Journal of Medicinal Chemistry. Jan, 2021 | Pubmed ID: 33400524 High Intratumoral CD8 T-cell Infiltration is Associated with Improved Survival in Prostate Cancer Patients Undergoing Radical Prostatectomy The Prostate. Jan, 2021 | Pubmed ID: 33085799 Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly Than Conventional Dendritic Cell (cDC) Cancers. Nov, 2020 | Pubmed ID: 33198125 Role of Tumor Microenvironment in the Efficacy of BCG Therapy Trends in Research. Oct, 2020 | Pubmed ID: 33178990 Monocytes Complexed to Platelets Differentiate into Functionally Deficient Dendritic Cells Journal of Leukocyte Biology. Jul, 2020 | Pubmed ID: 32663904 Quantitative Evaluation of Tumor-specific T Cells in Tumors and Lymphoid Tissues Methods in Enzymology. 2020 | Pubmed ID: 32122543 Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 01, 2020 | Pubmed ID: 31694832 Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of DsRNA-Driven Inflammation in the Human Tumor Microenvironment Cancer Research. 08, 2018 | Pubmed ID: 29853604 Tumor Immuno-Environment in Cancer Progression and Therapy Advances in Experimental Medicine and Biology. 2017 | Pubmed ID: 29275461 Een Murine Ommaya Xenograft-model om direct-gerichte therapie van leptomeningeale ziekte te bestuderen Vincent Law1,2, Margi Baldwin3, Ganesan Ramamoorthi4, Krithika Kodumudi4, Nam Tran1, Inna Smalley5, Derek Duckett6, Pawel Kalinski7, Brian Czerniecki4, Keiran S. M. Smalley2, Peter A. Forsyth1,2 1Department of Neuro-Oncology, H. Lee Moffitt Cancer Center & Research Institute, 2Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, 3Department of Comparative Medicine, University of South Florida, 4Department of Breast Oncology, H. Lee Moffitt Cancer Center & Research Institute, 5Department of Cancer Physiology, H. Lee Moffitt Cancer Center & Research Institute, 6Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, 7Department of Medical Oncology, Roswell Park Comprehensive Cancer Center JoVE 62033 Cancer Research
Een Murine Ommaya Xenograft-model om direct-gerichte therapie van leptomeningeale ziekte te bestuderen Vincent Law1,2, Margi Baldwin3, Ganesan Ramamoorthi4, Krithika Kodumudi4, Nam Tran1, Inna Smalley5, Derek Duckett6, Pawel Kalinski7, Brian Czerniecki4, Keiran S. M. Smalley2, Peter A. Forsyth1,2 1Department of Neuro-Oncology, H. Lee Moffitt Cancer Center & Research Institute, 2Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, 3Department of Comparative Medicine, University of South Florida, 4Department of Breast Oncology, H. Lee Moffitt Cancer Center & Research Institute, 5Department of Cancer Physiology, H. Lee Moffitt Cancer Center & Research Institute, 6Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, 7Department of Medical Oncology, Roswell Park Comprehensive Cancer Center JoVE 62033 Cancer Research
